Trial Profile

A Phase 2 Study to Evaluate the Sensitivity and Specificity of DBV1605, a Ready to Use Atopy Patch Test for the Diagnosis of Non-Immunoglobulin E Mediated Cow's Milk Allergy in Children

Status: Discontinued

Phase of Trial: Phase II

Latest Information Update: 30 Jun 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

12 Jun 2025 According to DBV Technologies media release, the company announced upcoming participation in the European Academy of Allergy and Clinical Immunology (EAACI) Congress, June 13 - 16, 2025, in Glasgow, United Kingdom. DBV will present poster and will also host a symposium and exhibit booth in the EAACI exhibit hall.
08 Mar 2024 Status changed from recruiting to discontinued (Date of the global end of the trial- 2023-11-02).
18 Oct 2023 This trial has been completed in Lithuania, according to European Clinical trials database record.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com